## **Core Concept**
Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). These drugs act on the gastric parietal cells to reduce acid secretion. The primary target of omeprazole is the **H+/K+ ATPase** (proton pump) located on the secretory surface of gastric parietal cells.

## **Why the Correct Answer is Right**
Omeprazole inhibits the **H+/K+ ATPase** enzyme, also known as the proton pump, which is responsible for the final step of acid production in the stomach. By irreversibly inhibiting this enzyme, omeprazole effectively blocks the secretion of gastric acid into the stomach lumen. This action results in reduced gastric acidity and is beneficial in treating conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not specify a known target for omeprazole or any other class of drugs that would relate to its mechanism of action.
- **Option B:** This option is incorrect as it does not accurately represent the mechanism or site of action of omeprazole.
- **Option C:** While this option might seem related, it is not the correct target for omeprazole.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that PPIs like omeprazole are most effective when taken before eating, as they need to be activated in the acidic environment of the stomach. Also, recall that PPIs irreversibly inhibit the proton pump, which means their effect lasts until new pumps are synthesized by the parietal cells, typically taking 24-48 hours.

## **Correct Answer:** D. H+/K+ ATPase.